Anish Patel

Companies

• Enliven Therapeutics, Inc.Chief operating officer Feb 27, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEnliven Therapeutics, Inc. ELVN235,011 shares²$9.0M at $38.33Feb 17, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 12, 2026Granted 20,000 shares of Enliven Therapeutics, Inc.²
• Jan 9, 2026Sold 243 shares at $28.50 of Enliven Therapeutics, Inc.³
• Jan 9, 2026Sold 48,057 shares at $27.98 of Enliven Therapeutics, Inc.³
• Dec 8, 2025Sold 1,705 shares at $21.78 of Enliven Therapeutics, Inc.⁴
• Dec 8, 2025Sold 4,958 shares at $20.76 of Enliven Therapeutics, Inc.⁴
• Nov 7, 2025Sold 613 shares at $17.94 of Enliven Therapeutics, Inc.⁵
• Nov 7, 2025Sold 6,054 shares at $17.35 of Enliven Therapeutics, Inc.⁵
• Oct 7, 2025Sold 6,667 shares at $20.10 of Enliven Therapeutics, Inc.⁶
• Sep 8, 2025Sold 6,667 shares at $20.24 of Enliven Therapeutics, Inc.⁷
• Aug 7, 2025Sold 405 shares at $18.93 of Enliven Therapeutics, Inc.⁸
• Aug 7, 2025Sold 6,262 shares at $18.20 of Enliven Therapeutics, Inc.⁸
• Jul 7, 2025Sold 305 shares at $20.69 of Enliven Therapeutics, Inc.⁹
• Jul 7, 2025Sold 6,362 shares at $19.75 of Enliven Therapeutics, Inc.⁹
• Jun 9, 2025Sold 60 shares at $21.16 of Enliven Therapeutics, Inc.¹⁰
• Jun 9, 2025Sold 6,607 shares at $20.33 of Enliven Therapeutics, Inc.¹⁰
• May 7, 2025Sold 104 shares at $19.87 of Enliven Therapeutics, Inc.¹¹
• May 7, 2025Sold 390 shares at $19.40 of Enliven Therapeutics, Inc.¹¹
• May 7, 2025Sold 6,173 shares at $18.30 of Enliven Therapeutics, Inc.¹¹
• Apr 7, 2025Sold 148 shares at $19.27 of Enliven Therapeutics, Inc.¹²
• Apr 7, 2025Sold 2,763 shares at $18.29 of Enliven Therapeutics, Inc.¹²
• Apr 7, 2025Sold 3,756 shares at $17.81 of Enliven Therapeutics, Inc.¹²
• Mar 7, 2025Sold 6,667 shares at $21.44 of Enliven Therapeutics, Inc.¹³
• Feb 7, 2025Sold 6,667 shares at $21.93 of Enliven Therapeutics, Inc.¹⁴
• Jan 7, 2025Sold 90 shares at $24.60 of Enliven Therapeutics, Inc.¹⁵
• Jan 7, 2025Sold 6,577 shares at $24.17 of Enliven Therapeutics, Inc.¹⁵